Abstract:Background: Group 2 innate lymphoid cells (ILC2s) are critical mediators of type 2 respiratory inflammation, releasing IL-5 and IL-13 and promoting the pulmonary eosinophilia associated with allergen provocation. Although ILC2s have been shown to promote eosinophil activities, the role of eosinophils in group 2 innate lymphoid cell (ILC2) responses is less well defined. Objective: We sought to investigate the role of eosinophils in activation of ILC2s in models of allergic asthma and in vitro. Methods: Inducible eosinophil-deficient mice were exposed to allergic respiratory inflammation models of asthma, such as ovalbumin or house dust mite challenge, or to innate models of type 2 airway inflammation, such as inhalation of IL-33. Eosinophil-specific IL-4/13-deficient mice were used to address the specific roles for eosinophil-derived cytokines. Direct cell interactions between ILC2s and eosinophils were assessed by in vitro culture experiments. Results: Targeted depletion of eosinophils resulted in significant reductions of total and IL-5+ and IL-13+ lung ILC2s in all models of respiratory inflammation. This correlated with reductions in IL-13 levels and mucus in the airway. Eosinophil-derived IL-4/13 was necessary for both eosinophil and ILC2 accumulation in lung in allergen models. In vitro, eosinophils released soluble mediators that induced ILC2 proliferation and G protein-coupled receptor-dependent chemotaxis of ILC2s. Coculture of ILC2s and IL-33-activated eosinophils resulted in transcriptome changes in both ILC2s and eosinophils, suggesting potential novel reciprocal interactions. Conclusion: These studies demonstrate that eosinophils play a reciprocal role in ILC2 effector functions as part of both adaptive and innate type 2 pulmonary inflammatory events.

Lipid droplet messengers

Alarmin-loaded extracellular lipid droplets induce airway neutrophil infiltration during type 2 inflammation

Angiotensin II Enhances Group 2 Innate Lymphoid Cell Responses Via AT1a During Airway Inflammation.

CCAAT/enhancer-binding Protein Δ is a Critical Mediator of Lipopolysaccharide-Induced Acute Lung Injury.

Lung Dysfunction in a Mouse Model of Inflammation is Dependent on T-cell-independent IL-13 Expression (54.18)

The Origin and Role of Innate Lymphoid Cells in the Lung

Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice

Group 2 innate lymphoid cells protect lung endothelial cells from pyroptosis in sepsis

Protective Role of Ilc2 in Sepsis-Induced Acute Lung Injury

Sensing and signaling of immunogenic extracellular RNAs restrain group 2 innate lymphoid cell-driven acute lung inflammation and airway hyperresponsiveness

RAGE-induced ILC2 Expansion in Acute Lung Injury Due to Haemorrhagic Shock.

The role of innate lymphoid cells in inlfammatory dermatosis

House dust mite allergen directly activates ILC2 cells via the TLR4 signaling pathway in allergic airway diseases

Maturation and specialization of group 2 innate lymphoid cells through the lung-gut axis

Cys-leukotrienes mediate lung dysfunction but not histopathologies in an IL-5/Eotaxin-2 double transgenic mouse model of severe asthma

The E3 Ligase VHL Controls Lung Inflammation by Regulating Epithelium-ILC2 Cross-talk

Modulating ILC2 function for treatment of type 2 airway diseases

Localization and site-specific cell-cell interactions of group 2 innate lymphoid cells

ILC2-derived LIF licences progress from tissue to systemic immunity

Hypoxia induces adrenomedullin from lung epithelia, stimulating ILC2 inflammation and immunity

Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma